Myriceric acid B
Myriceric acid B is a potent HIV-1 entry inhibitor targeting gp41. Myriceric acid B is an antitumor agent[1][2].
Product Specifications
CAS Number
55497-79-5
UNSPSC
12352005
Target
HIV
Type
Natural Products
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/myriceric-acid-b.html
Solubility
10 mM in DMSO
Smiles
OC1=C(O)C=CC(/C=C/C(OC[C@]23[C@@]4(C)[C@@](CC=C2[C@@]5([H])[C@](C(O)=O)(CCC(C)(C)C5)CC3)([H])[C@@]6([C@@](C(C)([C@@H](O)CC6)C)([H])CC4)C)=O)=C1
Molecular Formula
C39H54O7
Molecular Weight
634.84
References & Citations
[1]Eom HJ, et al. Cytotoxic Triterpenoids from the Barks of Betula platyphylla var. japonica. Chem Biodivers. 2017 Apr;14 (4) .|[2]Xia C, et al. The anti-HIV-1 entrance activity and mechanism of action of myriceric acid B from Rhoiptelea chiliantha Diels et Hand-Mazz. Chinese Pharmacological Bulletin, 2010: 447-452.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
HIV-1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY402068 100 µg
Sumo 3 (SUMO3) (NM_006936) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC681946-100 1x 100 µL
Filaggrin (Keratinocyte Differentiation Marker) (rFLG/1561), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
